Tenaya Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNYA and other ETFs, options, and stocks.

About TNYA

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine.

CEO

Faraz Ali

CEOFaraz Ali

Employees

Employees97

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2016

Founded2016

Employees

Employees97

TNYA Key Statistics

Market cap

70.74M

Market cap70.74M

Price-Earnings ratio

-0.37

Price-Earnings ratio-0.37

Dividend yield

—

Dividend yield—

Average volume

2.43M

Average volume2.43M

High today

$0.452

High today$0.452

Low today

$0.3901

Low today$0.3901

Open price

$0.43

Open price$0.43

Volume

1.81M

Volume1.81M

52 Week high

$4.60

52 Week high$4.60

52 Week low

$0.36

52 Week low$0.36

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own TNYA. This list is generated using Robinhood data, and it’s not a recommendation.

Tenaya Therapeutics

Why Robinhood?

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. Show more

TNYA Key Statistics

Analyst ratings

100%

People also own

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine.